CBIO
TD Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-64,210
| Closed | -$765K | – | 1348 |
|
|
2019
Q2 | $765K | Sell |
64,210
-10,100
| -14% | -$120K | ﹤0.01% | 1102 |
|
|
2019
Q1 | $926K | Sell |
74,310
-1,800
| -2% | -$22.4K | ﹤0.01% | 1056 |
|
|
2018
Q4 | $721K | Buy |
76,110
+3,438
| +5% | +$32.6K | ﹤0.01% | 1138 |
|
|
2018
Q3 | $1.05M | Buy |
72,672
+3,500
| +5% | +$50.4K | ﹤0.01% | 1153 |
|
|
2018
Q2 | $1.12M | Buy |
69,172
+12,700
| +22% | +$205K | ﹤0.01% | 1106 |
|
|
2018
Q1 | $917K | Buy |
56,472
+31,472
| +126% | +$511K | ﹤0.01% | 1082 |
|
|
2017
Q4 | $420K | Sell |
25,000
-300
| -1% | -$5.04K | ﹤0.01% | 1218 |
|
|
2017
Q3 | $354K | Sell |
25,300
-7,100
| -22% | -$99.3K | ﹤0.01% | 1213 |
|
|
2017
Q2 | $362K | Buy |
+32,400
| New | +$362K | ﹤0.01% | 1238 |
|